These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 21846841)
1. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. Liu L; Chen C; Gong W; Li Y; Edin ML; Zeldin DC; Wang DW J Pharmacol Exp Ther; 2011 Nov; 339(2):451-63. PubMed ID: 21846841 [TBL] [Abstract][Full Text] [Related]
2. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells. Gu S; Chen C; Jiang X; Zhang Z Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155 [TBL] [Abstract][Full Text] [Related]
3. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1. Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001 [TBL] [Abstract][Full Text] [Related]
4. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902 [TBL] [Abstract][Full Text] [Related]
5. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation. Jin HO; Seo SK; Woo SH; Lee HC; Kim ES; Yoo DH; Lee SJ; An S; Choe TB; Kim JI; Hong SI; Rhee CH; Park IC Lung Cancer; 2008 Sep; 61(3):317-27. PubMed ID: 18281123 [TBL] [Abstract][Full Text] [Related]
6. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation. Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928 [TBL] [Abstract][Full Text] [Related]
7. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK). Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268 [TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt. Choi YJ; Park JW; Suh SI; Mun KC; Bae JH; Song DK; Kim SP; Kwon TK Int J Oncol; 2002 Sep; 21(3):603-10. PubMed ID: 12168106 [TBL] [Abstract][Full Text] [Related]
9. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels. Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity. Zheng CY; Lam SK; Li YY; Ho JC Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414 [TBL] [Abstract][Full Text] [Related]
11. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway. Qu H; Tong D; Zhang Y; Kang K; Zhang Y; Chen L; Ren L Pharmazie; 2013 Oct; 68(10):839-45. PubMed ID: 24273890 [TBL] [Abstract][Full Text] [Related]
12. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation. Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739 [TBL] [Abstract][Full Text] [Related]
13. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells. Park MT; Kang YH; Park IC; Kim CH; Lee YS; Chung HY; Lee SJ Mol Cancer Ther; 2007 Jan; 6(1):82-92. PubMed ID: 17237268 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism. Bowling BD; Doudican N; Manga P; Orlow SJ Cancer Chemother Pharmacol; 2008 Dec; 63(1):37-43. PubMed ID: 18297286 [TBL] [Abstract][Full Text] [Related]
15. MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells. Golemovic M; Quintás-Cardama A; Manshouri T; Orsolic N; Duzkale H; Johansen M; Freireich EJ; Kantarjian H; Zingaro RA; Verstovsek S Invest New Drugs; 2010 Aug; 28(4):402-12. PubMed ID: 19468689 [TBL] [Abstract][Full Text] [Related]
16. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines. Kajiguchi T; Yamamoto K; Iida S; Ueda R; Emi N; Naoe T Cancer Sci; 2006 Jun; 97(6):540-5. PubMed ID: 16734734 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Iwama K; Nakajo S; Aiuchi T; Nakaya K Int J Cancer; 2001 May; 92(4):518-26. PubMed ID: 11304686 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells. Wang R; Xia L; Gabrilove J; Waxman S; Jing Y Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450 [TBL] [Abstract][Full Text] [Related]